BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8374874)

  • 1. Cancer in the augmented breast. Diagnosis and prognosis.
    Clark CP; Peters GN; O'Brien KM
    Cancer; 1993 Oct; 72(7):2170-4. PubMed ID: 8374874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping.
    Jakub JW; Ebert MD; Cantor A; Gardner M; Reintgen DS; Dupont EL; Cox CE; Shons AR
    Plast Reconstr Surg; 2004 Dec; 114(7):1737-42. PubMed ID: 15577343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer diagnosis and prognosis in augmented women.
    Handel N; Silverstein MJ
    Plast Reconstr Surg; 2006 Sep; 118(3):587-93; discussion 594-6. PubMed ID: 16932162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
    Heimann R; Munsell M; McBride R
    Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer after breast augmentation with silicone implants.
    Cahan AC; Ashikari R; Pressman P; Cody H; Hoffman S; Sherman JE
    Ann Surg Oncol; 1995 Mar; 2(2):121-5. PubMed ID: 7728564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in women after augmentation mammoplasty.
    Silverstein MJ; Handel N; Gamagami P; Waisman JR; Gierson ED; Rosser RJ; Steyskal R; Colburn W
    Arch Surg; 1988 Jun; 123(6):681-5. PubMed ID: 2835940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer after augmentation mammoplasty.
    Skinner KA; Silberman H; Dougherty W; Gamagami P; Waisman J; Sposto R; Silverstein MJ
    Ann Surg Oncol; 2001 Mar; 8(2):138-44. PubMed ID: 11258778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer diagnosis and prognosis in women augmented with silicone gel-filled implants.
    Silverstein MJ; Gierson ED; Gamagami P; Handel N; Waisman JR
    Cancer; 1990 Jul; 66(1):97-101. PubMed ID: 2162244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses.
    Silverstein MJ; Handel N; Gamagami P; Gierson ED; Furmanski M; Collins AR; Epstein M; Cohlan BF
    Eur J Cancer; 1992; 28(2-3):635-40. PubMed ID: 1591087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
    Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
    J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic mapping in patients with breast cancer and previous augmentation mammoplasty.
    Kaminski A; Amr D; Kimbrell ML; Difronzo LA
    Am Surg; 2007 Oct; 73(10):981-3. PubMed ID: 17983062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography in women with axillary lymphadenopathy and normal breasts on physical examination: value in detecting occult breast carcinoma.
    Leibman AJ; Kossoff MB
    AJR Am J Roentgenol; 1992 Sep; 159(3):493-5. PubMed ID: 1503012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of axillary dissection in mammographically detected carcinoma.
    Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
    J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary node status in nonpalpable breast cancer.
    Dowlatshahi K; Snider HC; Kim R
    Ann Surg Oncol; 1995 Sep; 2(5):424-8. PubMed ID: 7496837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Axillary lymph node dissection in clinically occult breast cancer].
    Le Bouëdec G; Pomel C; Chamussy E; Feillel V; de Latour M; Dauplat J
    Bull Cancer; 1996 Jul; 83(7):581-8. PubMed ID: 8868947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations of previous augmentation in subsequent breast reconstruction.
    Spear SL; Clemens MW; Dayan JH
    Aesthet Surg J; 2008; 28(3):285-93. PubMed ID: 19083539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.